FEBS J. 2005 Jan;272(1):2-15.

Towards discovery-driven translational research in breast cancer.

Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, Straten PT, Mouridsen H, Friis E, Holm D, Rank F, Gromov P.

Source

The Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark. jec@cancer.dk

Abstract

Discovery-driven translational research in breast cancer is moving steadily from the study of cell lines to the analysis of clinically relevant samples that, together with the ever increasing number of novel and powerful technologies available within genomics, proteomics and functional genomics, promise to have a major impact on the way breast cancer will be diagnosed, treated and monitored in the future. Here we present a brief report on long-term ongoing strategies at the Danish Centre for Translational Breast Cancer Research to search for markers for early detection and targets for therapeutic intervention, to identify signalling pathways affected in individual tumours, as well as to integrate multiplatform 'omic' data sets collected from tissue samples obtained from individual patients. The ultimate goal of this initiative is to coalesce knowledge-based complementary procedures into a systems biology approach to fight breast cancer.

PMID:: 15634327; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Tumor Markers, Biological

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Related citations

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. [Mol Cell Proteomics. 2003]
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.
Celis JE, Gromov P, Gromova I, Moreira JM, Cabezón T, Ambartsumian N, Grigorian M, Lukanidin E, Thor Straten P, Guldberg P, et al. Mol Cell Proteomics. 2003 Jun; 2(6):369-77. Epub 2003 Jun 25.
Review High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy. [Breast Cancer Res. 2006]
Review High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
Davis MA, Hanash S. Breast Cancer Res. 2006; 8(6):217.
Review Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery. [Future Oncol. 2008]
Review Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.
Bertucci F, Goncalves A. Future Oncol. 2008 Apr; 4(2):271-87.
Review Proteomics: new technologies and clinical applications. [Eur J Cancer. 2008]
Review Proteomics: new technologies and clinical applications.
Latterich M, Abramovitz M, Leyland-Jones B. Eur J Cancer. 2008 Dec; 44(18):2737-41. Epub 2008 Nov 1.
Review Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. [Breast Cancer Res. 2008]
Review Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.
Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, et al. Breast Cancer Res. 2008; 10(2):R26. Epub 2008 Mar 27.

See reviews... See all...

Cited by 5 PubMed Central articles

A framework and mechanistically focused, in silico method for enabling rational translational research. [Summit on Translat Bioinforma. 2008]
A framework and mechanistically focused, in silico method for enabling rational translational research.
Hunt CA, Baranzini S, Matthay MA, Park S. Summit on Translat Bioinforma. 2008 Mar 1; 2008:46-50. Epub 2008 Mar 1.
Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. [Mol Cell Proteomics. 2010]
Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.
Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, Chen JK, Lin YJ, Chang PY, Wang CJ, et al. Mol Cell Proteomics. 2010 Sep; 9(9):1873-84. Epub 2010 May 25.
Review Cancer treatment: the combination of vaccination with other therapies. [Cancer Immunol Immunother. 2008]
Review Cancer treatment: the combination of vaccination with other therapies.
Andersen MH, Sørensen RB, Schrama D, Svane IM, Becker JC, Thor Straten P. Cancer Immunol Immunother. 2008 Nov; 57(11):1735-43. Epub 2008 Feb 20.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Towards discovery-driven translational research in breast cancer.
Towards discovery-driven translational research in breast cancer.
FEBS J. 2005 Jan ;272(1):2-15.

PubMed
Molecular cloning of the maize gene crp1 reveals similarity between regulators o...
Molecular cloning of the maize gene crp1 reveals similarity between regulators of mitochondrial and chloroplast gene expression.
EMBO J. 1999 May 4 ;18(9):2621-30.

PubMed
Use of botulinum toxin type A injection for neuropathic pain after trigeminal ne...
Use of botulinum toxin type A injection for neuropathic pain after trigeminal nerve injury.
Pain Med. 2010 Apr ;11(4):630-2. Epub 2010 Mar 4 .

PubMed
From endothelial dysfunction to atherosclerosis.
From endothelial dysfunction to atherosclerosis.
Autoimmun Rev. 2010 Oct ;9(12):830-4. Epub 2010 Jul 30 .

PubMed
MafA and MafB regulate genes critical to beta-cells in a unique temporal manner.
MafA and MafB regulate genes critical to beta-cells in a unique temporal manner.
Diabetes. 2010 Oct ;59(10):2530-9. Epub 2010 Jul 13 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: